EAU 2019 Prostate Cancer - Results from #60

Viewing 61-79 of 79 articles

EAU 2019: Does Size Matter? A Comparison of Gleason Score Concordance Rate Between 23 Belgian Centers

EAU 2019: Local Treatment in Oligometastatic Disease

EAU 2019: Trends in Prostate Biopsy Criteria and Outcomes from 2010 to Present: The Columbia Experience

EAU 2019: The Medical Oncologist’s Perspective on the Treatment for Prostate Cancer

EAU 2019: The Urologist’s Perspective on Surgery for Prostate Cancer

EAU 2019: MRI Alone Should Not be Considered as a Stand-alone Test for Disease Reclassification of Men in Active Surveillance

EAU 2019: The Imaging Specialist’s Perspective on MRI for Prostate Cancer

EAU 2019: The Patient’s Perspective on Prostate Cancer

EAU 2019: Total Cancer Location Density Score - A Predictor of Clinical Progression in Patients on Active Surveillance for Prostate Cancer

EAU 2019: The Urologist's Perspective on Focal Therapy for Prostate Cancer

EAU 2019: The Radiation Oncologist’s Perspective on the Treatment of Prostate Cancer

EAU 2019: Added Value of Concomitant Systematic Biopsies in Predicting Upgrading in Localized Prostate Cancer Diagnosed by MRI-Targeted Biopsy

EAU 2019: Tumor Locations in the Prostate Gland Affect the Incidence, Clinicopathological Features and Prognosis of Prostate Cancer

EAU 2019: Changes in Gleason Score Misclassification Between Diagnostic Biopsies and Radical Prostatectomy Specimens – A Nationwide Analysis

EAU 2019: Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database (NCDB) Analysis

EAU 2019: Examining the Limits of Active Surveillance Eligibility: Validation of a Swedish National Prostate Cancer Register (NPCR) Observational Study

EAU 2019: Low Free Testosterone is an Independent Risk Factor for High Grade Prostate Cancer

EAU 2019: Does Time Spent on Active Surveillance Adversely Affect the Pathologic and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?

EAU 2019: A Novel Predictor of Clinical Progression in Patients on Active Surveillance for Prostate Cancer

1
2
3
4